Author
Listed:
- Norzawani Buang
(Imperial College London)
- Lunnathaya Tapeng
(Imperial College London)
- Victor Gray
(Imperial College London)
- Alessandro Sardini
(Imperial College London)
- Chad Whilding
(Imperial College London)
- Liz Lightstone
(Imperial College London
Imperial College Healthcare NHS Trust)
- Thomas D. Cairns
(Imperial College Healthcare NHS Trust)
- Matthew C. Pickering
(Imperial College London
Imperial College Healthcare NHS Trust)
- Jacques Behmoaras
(Imperial College London)
- Guang Sheng Ling
(Imperial College London
The University of Hong Kong)
- Marina Botto
(Imperial College London
Imperial College Healthcare NHS Trust)
Abstract
The majority of patients with systemic lupus erythematosus (SLE) have high expression of type I IFN-stimulated genes. Mitochondrial abnormalities have also been reported, but the contribution of type I IFN exposure to these changes is unknown. Here, we show downregulation of mitochondria-derived genes and mitochondria-associated metabolic pathways in IFN-High patients from transcriptomic analysis of CD4+ and CD8+ T cells. CD8+ T cells from these patients have enlarged mitochondria and lower spare respiratory capacity associated with increased cell death upon rechallenge with TCR stimulation. These mitochondrial abnormalities can be phenocopied by exposing CD8+ T cells from healthy volunteers to type I IFN and TCR stimulation. Mechanistically these ‘SLE-like’ conditions increase CD8+ T cell NAD+ consumption resulting in impaired mitochondrial respiration and reduced cell viability, both of which can be rectified by NAD+ supplementation. Our data suggest that type I IFN exposure contributes to SLE pathogenesis by promoting CD8+ T cell death via metabolic rewiring.
Suggested Citation
Norzawani Buang & Lunnathaya Tapeng & Victor Gray & Alessandro Sardini & Chad Whilding & Liz Lightstone & Thomas D. Cairns & Matthew C. Pickering & Jacques Behmoaras & Guang Sheng Ling & Marina Botto, 2021.
"Type I interferons affect the metabolic fitness of CD8+ T cells from patients with systemic lupus erythematosus,"
Nature Communications, Nature, vol. 12(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22312-y
DOI: 10.1038/s41467-021-22312-y
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22312-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.